The TAVR 30-day morbidity/mortality composite is a hierarchical, multiple outcome risk model that estimates risk standardized results (reported as a “site difference”) for the purpose of benchmarking site performance. This measure estimates hospital risk standardized site difference for 5 endpoints (death from all causes, stroke, major or life-threatening bleeding, acute kidney injury, moderate or severe paravalvular aortic regurgitation) within 30 days following transcatheter aortic valve replacement. The measure uses clinical data available in the STS/ACC TVT Registry for risk adjustment for the purposes of benchmarking site to site performance on a rolling 3-year timeframe.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
A composite outcome including all-cause death, stroke, major or life threatening bleeding, acute kidney injury, moderate or severe paravalvular aortic regurgitation within 30 days following transcatheter aortic valve replacement (TAVR).
If a patient experiences multiple outcomes captured in the overall rank composite measure, the outcome with the highest rank is assigned.
-
1.15 Denominator
Patients who had TAVR.
-
Exclusions
Hospitals are excluded if they do not meet eligibility criteria noted in S.7.
Patients are excluded if any of the following occur:
1) They did not have a first-time TAVR in the episode of care (admission),
2) The TAVR was subsequent to another procedure in the Registry (other TAVR, Mitral Leaflet Clip and/or TMVR) during that admission.
3) The patient is readmitted for a repeat TAVR (re-admission) and the initial TAVR was performed during the rolling 3-year timeframe for the measure.
4) They are in TVT Registry sponsored research studies (identified with research study=yes and research study device used during procedure).
-
Most Recent Endorsement Activity - OLDEndorsed Cardiovascular Spring 2021Initial EndorsementLast Updated
-
StewardAmerican College of CardiologySteward Organization Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)
-
Planned Use
-